Back to AQR CAPITAL MANAGEMENT LLC AQR CAPITAL MANAGEMENT LLC

TRDATRDA
8 quarters

Position history for AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC's holdings in ENTRADA THERAPEUTICS INC

Yes. AQR Capital Management holds 699,537 shares of TRDA (Entrada Therapeutics), worth $5.1M, as of its Q2 2026 13F filing. It increased the position from 79,493 shares in Q1 2026. AQR Capital Management has held TRDA since Q3 2024, across 8 quarterly 13F filings.

Current Value

$5.1M

Current Shares

699,537

Total Value Change

+$4.5M

Total Shares Change

+660,069

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
699,537
+780.0%
$5.1M0.0%$7.36
44
2026-Q1
Increased
79,493
+202.8%
$1M0.0%$11.85
40
2025-Q4
Increased
26,254
+87.7%
$269,8910.0%$10.09
36
2025-Q3
Decreased
13,991
-60.7%
$81,1480.0%$5.84
0
2025-Q2
Increased
35,620
+15.2%
$239,3660.0%$6.91
26
2025-Q1
Decreased
30,919
-43.8%
$279,5070.0%$9.56
0
2024-Q4
Increased
54,979
+39.3%
$950,5870.0%$17.37
33
2024-Q3
New
39,468
-
$630,6990.0%$16.45
34

Other major holders of TRDA: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used